Open AccessOpioids in the United Kingdom: safety and surveillance during COVID-19
Author(s) -
Vicki Osborne
Publication year - 2021
Publication title -
current opinion in psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.66
H-Index - 90
eISSN - 1473-6578
pISSN - 0951-7367
DOI - 10.1097/yco.0000000000000719
Subject(s) - pandemic , medicine , covid-19 , health care , agency (philosophy) , medical emergency , political science , disease , philosophy , epistemology , pathology , infectious disease (medical specialty) , law
Opioid use is prevalent in the United Kingdom and prior to the COVID-19 pandemic it had been recognized that the safety of opioids was an important issue to be monitored by the UK medicines regulatory agency. With the emergence of COVID-19, this requirement has been even greater. This review was undertaken to determine the impact of the pandemic on safety and surveillance of opioids in the United Kingdom.